| [1] |
Mayans L. Nephrolithiasis[J]. Prim Care, 2019, 46(2): 203-212.
|
| [2] |
Kittanamongkolchai W, Vaughan LE, Enders FT, et al. The changing incidence and presentation of urinary stones over 3 decades[J]. Mayo Clin Proc, 2018, 93(3): 291-299.
|
| [3] |
D'Costa MR, Pais VM, Rule AD. Leave no stone unturned: defining recurrence in kidney stone formers[J]. Curr Opin Nephrol Hypertens, 2019, 28(2): 148-153.
|
| [4] |
王友铭, 许长宝, 王晓甫, 等. 河南省泌尿系结石住院患者流行病学特点及分析[J]. 临床泌尿外科杂志, 2021, 36(6): 458-463.
|
| [5] |
Ye Z, Zeng G, Yang H, et al. The status and characteristics of urinary stone composition in China[J]. BJU Int, 2020, 125(6): 801-809.
|
| [6] |
Wang Z, Zhang Y, Zhang J, et al. Recent advances on the mechanisms of kidney stone formation (Review)[J]. Int J Mol Med, 2021, 48(2): 149.
|
| [7] |
Whittamore JM, Hatch M. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man[J]. Urolithiasis, 2017, 45(1): 89-108.
|
| [8] |
Ticinesi A, Nouvenne A, Meschi T. Gut microbiome and kidney stone disease: not just an Oxalobacter story[J]. Kidney Int, 2019, 96(1): 25-27.
|
| [9] |
Evenepoel P, Poesen R, Meijers B. The gut-kidney axis[J]. Pediatr Nephrol, 2017, 32(11): 2005-2014.
|
| [10] |
熊磊, 吕建林. 肠道微生物群落与草酸钙结石的关系研究进展[J]. 现代泌尿外科杂志, 2020, 25(8): 756-759.
|
| [11] |
Miller AW, Orr T, Dearing D, et al. Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet[J]. ISME J, 2019, 13(6): 1379-1390.
|
| [12] |
Lieske JC. Probiotics for prevention of urinary stones[J]. Ann Transl Med, 2017, 5(2): 29.
|
| [13] |
Allison MJ, Dawson KA, Mayberry WR, et al. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract[J]. Arch Microbiol, 1985, 141(1): 1-7.
|
| [14] |
Pebenito AM, Liu M, Nazzal L, et al. Development of a humanized murine model for the study of oxalobacter formigenes intestinal colonization[J]. J Infect Dis, 2019, 220(11): 1848-1858.
|
| [15] |
Arvans D, Jung YC, Antonopoulos D, et al. Oxalobacter formigenes-Derived bioactive factors stimulate oxalate transport by intestinal epithelial cells[J]. J Am Soc Nephrol, 2017, 28(3): 876-887.
|
| [16] |
Stern JM, Urban-Maldonado M, Usyk M, et al. Fecal transplant modifies urine chemistry risk factors for urinary stone disease[J]. Physiol Rep, 2019, 7(4): e14012.
|
| [17] |
Daniel SL, Moradi L, Paiste H, et al. Forty years of oxalobacter formigenes, a gutsy oxalate-degrading specialist[J]. Appl Environ Microbiol, 2021, 87(18): e0054421.
|
| [18] |
张帝, 汤晓静, 高远, 等. 产甲酸草酸杆菌预防草酸钙肾结石的作用[J]. 中华肾脏病杂志, 2019, 35(4): 288-294.
|
| [19] |
Kaufman DW, Kelly JP, Curhan GC, et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones[J]. J Am Soc Nephrol, 2008, 19(6): 1197-1203.
|
| [20] |
Tavasoli S, Alebouyeh M, Naji M, et al. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study[J]. BJU Int, 2020, 125(1): 133-143.
|
| [21] |
Miller AW, Oakeson KF, Dale C, et al. Microbial community transplant results in increased and long-term oxalate degradation[J]. Microb Ecol, 2016, 72(2): 470-478.
|
| [22] |
Kharlamb V, Schelker J, Francois F, et al. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes[J]. J Endourol, 2011, 25(11): 1781-1785.
|
| [23] |
PeBenito A, Nazzal L, Wang C, et al. Comparative prevalence of Oxalobacter formigenes in three human populations[J]. Sci Rep, 2019, 9(1): 574.
|
| [24] |
Nazzal L, Francois F, Henderson N, et al. Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretion[J]. Sci Rep, 2021, 11(1): 16428.
|
| [25] |
Liu M, Koh H, Kurtz ZD, et al. Oxalobacter formigenes-associated host features and microbial community structures examined using the American Gut Project[J]. Microbiome, 2017, 5(1): 108.
|
| [26] |
Chen YY, Chen DQ, Chen L, et al. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease[J]. J Transl Med, 2019, 17(1): 5.
|
| [27] |
Pedro RN, Aslam AU, Bello JO, et al. Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis[J]. Urolithiasis, 2020, 48(4): 285-301.
|
| [28] |
Suryavanshi MV, Bhute SS, Gune RP, et al. Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease[J]. Sci Rep, 2018, 8(1): 16598.
|
| [29] |
Ellis ME, Mobley JA, Holmes RP, et al. Proteome dynamics of the specialist oxalate degrader Oxalobacter formigenes[J]. J Proteomics Bioinform, 2016, 9(1): 19-24.
|
| [30] |
Ellis ML, Dowell AE, Li X, et al. Probiotic properties of Oxalobacter formigenes: an in vitro examination[J]. Arch Microbiol, 2016, 198(10): 1019-1026.
|
| [31] |
Milliner D, Hoppe B, Groothoff J. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria[J]. Urolithiasis, 2018, 46(4): 313-323.
|
| [32] |
Maresca D, Zotta T, Mauriello G. Adaptation to aerobic environment of lactobacillus johnsonii/gasseri strains[J]. Front Microbiol, 2018, 9: 157.
|
| [33] |
Martín R, Langella P. Emerging health concepts in the probiotics field: streamlining the definitions[J]. Front Microbiol, 2019, 10: 1047.
|
| [34] |
Le B, Yang SH. Efficacy of Lactobacillus plantarum in prevention of inflammatory bowel disease[J]. Toxicol Rep, 2018, 5: 314-317.
|
| [35] |
Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases[J]. Front Microbiol, 2018, 9: 757.
|
| [36] |
刘建利, 何旭, 孙钦飞. 降解草酸盐乳酸菌株的筛选及其酸乳发酵特性[J]. 食品工业科技, 2021, 42(12): 111-118.
|
| [37] |
Sadaf H, Raza SI, Hassan SW. Role of gut microbiota against calcium oxalate[J]. Microb Pathog, 2017, 109: 287-291.
|
| [38] |
国立东, 王丽群, 于纯淼, 等. 乳酸菌降解草酸盐活性及机制研究进展[J]. 食品科学, 2018, 39(3): 324-329.
|
| [39] |
Paul E, Albert A, Ponnusamy S, et al. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats[J]. Microbiol Res, 2018, 215: 65-75.
|
| [40] |
Giardina S, Scilironi C, Michelotti A, et al. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria[J]. J Food Sci, 2014, 79(3): M384-M390.
|
| [41] |
Wei Z, Cui Y, Tian L, et al. Probiotic Lactiplantibacillus plantarum N-1 could prevent ethylene glycol-induced kidney stones by regulating gut microbiota and enhancing intestinal barrier function[J]. FASEB J, 2021, 35(11): e21937.
|
| [42] |
Zampini A, Nguyen AH, Rose E, et al. Defining dysbiosis in patients with urolithiasis[J]. Sci Rep, 2019, 9(1): 5425.
|
| [43] |
Campieri C, Campieri M, Bertuzzi V, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration[J]. Kidney Int, 2001, 60(3): 1097-1105.
|
| [44] |
Ferraz RR, Marques NC, Froeder L, et al. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients[J]. Urol Res, 2009, 37(2): 95-100.
|
| [45] |
Lieske JC, Tremaine WJ, De Simone C, et al. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation[J]. Kidney Int, 2010, 78(11): 1178-1185.
|
| [46] |
Siener R, Bade DJ, Hesse A, et al. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria[J]. J Transl Med, 2013, 11: 306.
|
| [47] |
Al-Wahsh I, Wu Y, Liebman M. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects[J]. Urol Res, 2012, 40(3): 191-196.
|
| [48] |
Hidalgo-Cantabrana C, Delgado S, Ruiz L, et al. Bifidobacteria and their health-promoting effects[J]. Microbiol Spectr, 2017, 5(3).
|
| [49] |
Turroni S, Bendazzoli C, Dipalo S C, et al. Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes[J]. Appl Environ Microbiol, 2010, 76(16): 5609-5620.
|
| [50] |
火玮. 肠道菌群对草酸钙结石形成影响进展[J]. 国际泌尿系统杂志, 2019, 39(5): 924-926.
|
| [51] |
Mehra Y, Rajesh NG, Viswanathan P. Analysis and characterization of lactobacillus paragasseri and lacticaseibacillus paracasei: two probiotic bacteria that can degrade intestinal oxalate in hyperoxaluric rats[J]. Probiotics Antimicrob Proteins, 2022, 14(5): 854-872.
|
| [52] |
Arafa A, Eshak ES, Iso H. Oxalates, urinary stones and risk of cardiovascular diseases[J]. Med Hypotheses, 2020, 137: 109570.
|
| [53] |
Ito H, Miura N, Masai M, et al. Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1[J]. Int J Urol, 1996, 3(1): 31-34.
|
| [54] |
Ito H, Kotake T, Masai M. In vitro degradation of oxalic acid by human feces[J]. Int J Urol, 1996, 3(3): 207-211.
|
| [55] |
Fiore E, van Tyne D, Gilmore MS. Pathogenicity of enterococci[J]. Microbiol Spectr, 2019, 7(4): 10.
|
| [56] |
Ramos S, Silva V, Dapkevicius MLE, et al. Enterococci, from harmless bacteria to a pathogen[J]. Microorganisms, 2020, 8(8): 1118.
|
| [57] |
Amimanan P, Tavichakorntrakool R, Fong-Ngern K, et al. Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation[J]. Sci Rep, 2017, 7(1): 2953.
|
| [58] |
赖德辉, 李名钊, 盛明, 等. 表达甲酰辅酶A转移酶的大肠杆菌对大鼠尿草酸浓度的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(5): 352-355.
|
| [59] |
Chapman CMC, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains?[J]. Eur J Nutr, 2011, 50(1): 1-17.
|